Atractylenolide III Attenuates Angiogenesis in Gastric Precancerous Lesions Through the Downregulation of Delta-Like Ligand 4

Background: Blocking and even reversing gastric precancerous lesions (GPL) is a key measure to lower the incidence of gastric cancer. Atractylenolide III (AT-III) is a mainly active component of the Atractylodes rhizome and has been widely used in tumor treatment. However, the effects of AT-III on G...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ying, Wang, Jundong, Zhao, Maoyuan, Xia, Ting, Liu, Qingsong, Chen, Nianzhi, Liao, Wenhao, Zeng, Zhongzhen, You, Fengming, Zeng, Jinhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282052/
https://www.ncbi.nlm.nih.gov/pubmed/35846998
http://dx.doi.org/10.3389/fphar.2022.797805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282052/
https://www.ncbi.nlm.nih.gov/pubmed/35846998
http://dx.doi.org/10.3389/fphar.2022.797805

Ejemplares similares